View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Carfilzomib 56 / Dexamethasone 20, Multiple Myeloma, Cycle 2+
Protocol-ID: 734 V1.0 (Mini), CARF56/DEXA20, MM, C2+Indication(s)
- Multiple Myeloma; ICD-10 C90.-, C90.0-
Links
- European Commission Approves Extended Indication For Amgen's Kyprolis® (Carfilzomib) For The Treatment Of Relapsed Multiple Myeloma Patients [URL]
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 15.05.2021